Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54680
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSantos-Lasaosa, S-
dc.contributor.authorBelvís, R-
dc.contributor.authorCuadrado, M L-
dc.contributor.authorDíaz-Insa, S-
dc.contributor.authorGago-Veiga, A-
dc.contributor.authorGuerrero-Peral, A L-
dc.contributor.authorHuerta, M-
dc.contributor.authorIrimia, P-
dc.contributor.authorLáinez, J M-
dc.contributor.authorLatorre, Germán-
dc.contributor.authorLeira, R-
dc.contributor.authorPascual, J-
dc.contributor.authorPorta-Etessam, J-
dc.contributor.authorSánchez Del Río, M-
dc.contributor.authorViguera, J-
dc.contributor.authorPozo-Rosich, P-
dc.date.accessioned2022-07-21T06:35:13Z-
dc.date.available2022-07-21T06:35:13Z-
dc.date.issued2019-07-17-
dc.identifier.citationSantos-Lasaosa S, Belvís R, Cuadrado ML, Díaz-Insa S, Gago-Veiga A, Guerrero-Peral AL, Huerta M, Irimia P, Láinez JM, Latorre G, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera J, Pozo-Rosich P. Calcitonin gene-related peptide in migraine: from pathophysiology to treatment. Neurologia (Engl Ed). 2019 Jul 17:S0213-4853(19)30075-1. English, Spanish. doi: 10.1016/j.nrl.2019.03.013. Epub ahead of print. PMID: 31326215.es_ES
dc.identifier.issn0213-4853-
dc.identifier.urihttps://hdl.handle.net/20.500.12530/54680-
dc.description.abstractIt has been observed in recent years that levels of such molecules as calcitonin gene-related peptide (CGRP) and, to a lesser extent, the pituitary adenylate cyclase-activating peptide are elevated during migraine attacks and in chronic migraine, both in the cerebrospinal fluid and in the serum. Pharmacological reduction of these proteins is clinically significant, with an improvement in patients' migraines. It therefore seems logical that one of the main lines of migraine research should be based on the role of CGRP in the pathophysiology of this entity.es_ES
dc.language.isoeses_ES
dc.publisherElsevier BVes_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectAnticuerpos monoclonaleses_ES
dc.subjectCGRPes_ES
dc.subjectChronic migrainees_ES
dc.subjectGepanteses_ES
dc.subjectGepantses_ES
dc.subjectMigrainees_ES
dc.subjectMigrañaes_ES
dc.subjectMigraña crónicaes_ES
dc.subjectMonoclonal antibodieses_ES
dc.subject.meshAntibodies, Monoclonales_ES
dc.subject.meshMigraine Disorderses_ES
dc.subject.meshCalcitonin Gene-Related Peptide Receptor Antagonistses_ES
dc.titleCGRP en migraña: de la fisiopatología a la terapéuticaes_ES
dc.typeArtículoes_ES
dc.identifier.pubmedID31326215es_ES
dc.format.volume37es_ES
dc.format.page390-402es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1578-1968-
dc.relation.publisherversionhttps://doi.org/10.1016/j.nrl.2019.03.013es_ES
dc.identifier.journalNeurologia (Barcelona, Spain)es_ES
dc.identifier.journalabbreviationNeurologia (Barc)es_ES
dc.contributor.authoraffiliationHospital Universitario de Fuenlabrada. Servicio de Medicina Interna. Neurologíaes_ES
dc.format.number5es_ES
dc.subject.decsAnticuerpos Monoclonaleses_ES
dc.subject.decsTrastornos Migrañososes_ES
dc.subject.decsAntagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitoninaes_ES
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
Neurologia español.pdf563.12 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons